Loading…
Our read is that NAD+ IV therapy is a well-supported option for improving well-being, vigor, and sleep, though direct comparative trials are lacking.
Our read is that NAD+ IV therapy, particularly with a 750mg infusion protocol, is widely adopted and effective for improving well-being, sleep, and vigor. Andrew Huberman suggests that doses between 500-1000mg can lead to rapid symptom improvement and may combat systemic inflammation.
However, the reported benefits are difficult to disentangle from placebo, and direct comparative clinical trials against other NAD precursors are lacking.
Andrew Huberman suggests that administering NAD infusions more slowly can make them more tolerable, with a 750mg infusion over 45 minutes potentially leading to rapid symptom improvement.
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Andrew Huberman notes that NAD infusions can cause temporary discomfort, including nausea, chest pressure, and leg pressure. He also cautions that the unpleasant side effects of intravenous NAD infusions should not be interpreted as evidence of physiological benefit. The reported benefits of intravenous NAD infusions are difficult to disentangle from placebo or other substances.
The verdict would change if direct comparative clinical trials demonstrated that NAD infusions are not more effective at increasing cellular NAD levels than NR or NMN, or if further research clarified the extent to which reported benefits are due to placebo or other substances.
Benefits hold across the populations where it's been tested.
Mechanistic and trial evidence converge on a real, replicable effect.
Mechanistic and trial evidence converge on a real, replicable effect.
Benefits hold across the populations where it's been tested.
Benefits hold across the populations where it's been tested.
Confounding and publication bias inflate the apparent benefit.
The headline effect shrinks once you account for trial quality.
Animal-model results don't translate to the human protocol being recommended.
Animal-model results don't translate to the human protocol being recommended.
Most of the support comes from short or small studies.